Stoke Therapeutics, Inc. (STOK): 10-Q filed Nov 3, 2026

Form type

10-Q

Filing date

Nov 3, 2026

Accession number

0001193125-26-445326

Filer

Stoke Therapeutics, Inc. (CIK 1623526)